Currently predicting for Thu, 4 Jun 2026

OMER Prediction Chart

OMER Predictions History

Latest community submissions for OMER.
Predictor Target Session Target Price Result Direction Accuracy Score
Nov 12, 2025 Bullish $6.89 X 0
Jul 28, 2025 $3.70 -3.44% $4.15 X 89.11% 0
Jul 28, 2025 $3.75 -2.15% $4.15 X 90.30% 0
rskfreespirit rskfreespirit Amateur
Jul 28, 2025 $4.19 +16.71% $4.15 V 99.04% 2
Jan 15, 2025 $9.04 +5.20% $8.90 V 98.46% 1
Jan 15, 2025 $8.87 +3.25% $8.90 V 99.65% 5
Jan 15, 2025 Bearish $8.90 X 0
Jan 7, 2025 $10.34 -4.59% $10.17 V 98.30% 1
Jan 7, 2025 $10.53 -2.87% $10.17 V 96.47% 1
Skagitqg Skagitqg Merchant
Jan 7, 2025 Bullish $10.17 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for OMER with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT OMEROS CORPORATION
Omeros
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical programs include Narsoplimab (OMS721/MASP-2) that has completed pivotal studies for hematopoietic stem-cell tr...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE